MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children

• Status: Completed
• Trial end date: 2010-04-01
• Target enrollment: 0
• Participant gender: All

Summary

1. To test for equivalence in terms of catch-up growth between the 2 therapeutic regimens

2. To specify the best period of treatment

3. To assess the efficacy of treatment based on final adult height of these children

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanofi

Criteria

Inclusion Criteria:

• Pre-pubertal children of either sex presenting with severe early onset intrauterine growth retardation (I.U.G.R.)

• Height Less Than or Equal to -3 SD

Exclusion Criteria:

• Age less than 3 years

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.